ofloxacin has been researched along with Cronobacter Infections in 20 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this open-label, single-arm, multicenter study was to assess the efficacy and safety of levofloxacin in the treatment of complicated urinary tract infections." | 9.10 | [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections]. ( Marchetti, F; Trinchieri, A, 2003) |
| "Comparison of efficacy and safety of sparfloxacin vs ofloxacin for treatment of acute bacterial exacerbations of chronic bronchitis (ABECB)." | 9.08 | Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. ( Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D, 1998) |
| "The objective of this open-label, single-arm, multicenter study was to assess the efficacy and safety of levofloxacin in the treatment of complicated urinary tract infections." | 5.10 | [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections]. ( Marchetti, F; Trinchieri, A, 2003) |
| "Comparison of efficacy and safety of sparfloxacin vs ofloxacin for treatment of acute bacterial exacerbations of chronic bronchitis (ABECB)." | 5.08 | Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. ( Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D, 1998) |
| " It was used alone 26 times and on 6 occasions it was associated with rifampin on 6 staphylococcal infections." | 3.67 | [Ofloxacin (RU 43280). Clinical study]. ( Bertrand, A; Despaux, E; Janbon, F; Jonquet, O; Reynes, J, 1987) |
| "The empiric treatment of acute pyelonephritis (APN) with third generation cephalosporins (3GC) or fluoroquinolones (FQ) has been challenged by Escherichia coli resistance reported by community surveillance networks." | 1.40 | Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors. ( Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H, 2014) |
| "A 55 year-old male patient with chronic renal failure was hospitalized in intensive care unit following cardiopulmonary arrest." | 1.38 | [A case of ventilator-associated pneumonia due to Pantoea agglomerans]. ( Altın, N; Argun, C; Canbakan, B; Cesur, S; Koldaş, K; Kurşun, O; Sencan, I; Unal, N, 2012) |
| "Cellulitis is usually caused by organisms such as beta-hemolytic streptococci and Staphylococcus aureus." | 1.32 | Sepsis in a renal transplant recipient due to Citrobacter braakii. ( Agraharkar, ML; Gupta, R; Rauf, SJ; Singh, S; Smith, J, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quiroga, MP | 1 |
| Andres, P | 1 |
| Petroni, A | 1 |
| Soler Bistué, AJ | 1 |
| Guerriero, L | 1 |
| Vargas, LJ | 1 |
| Zorreguieta, A | 1 |
| Tokumoto, M | 1 |
| Quiroga, C | 1 |
| Tolmasky, ME | 1 |
| Galas, M | 1 |
| Centrón, D | 1 |
| Lecuru, M | 1 |
| Daniau, C | 1 |
| Alfandari, S | 1 |
| Dumartin, C | 1 |
| Bajolet, O | 1 |
| Blanchard, H | 1 |
| Simon, L | 1 |
| Colomb-Cotinat, M | 1 |
| Etienne, M | 1 |
| Van Elslande, H | 1 |
| Choplin-Renard, J | 1 |
| Pestel-Caron, M | 1 |
| Caron, F | 1 |
| Rocke, J | 1 |
| Roydhouse, T | 1 |
| Spencer, T | 1 |
| Zhang, J | 1 |
| Ye, LP | 1 |
| Li, W | 1 |
| Shen, LY | 1 |
| Salman, S | 1 |
| Young, M | 1 |
| Van Sickels, JE | 1 |
| Shao, Y | 1 |
| Xiong, Z | 1 |
| Li, X | 1 |
| Hu, L | 1 |
| Shen, J | 1 |
| Li, T | 1 |
| Hu, F | 1 |
| Chen, S | 1 |
| Kurşun, O | 1 |
| Unal, N | 1 |
| Cesur, S | 1 |
| Altın, N | 1 |
| Canbakan, B | 1 |
| Argun, C | 1 |
| Koldaş, K | 1 |
| Sencan, I | 1 |
| Toh, HS | 1 |
| Chuang, YC | 1 |
| Huang, CC | 1 |
| Lee, YL | 1 |
| Liu, YM | 1 |
| Ho, CM | 1 |
| Lu, PL | 1 |
| Liu, CE | 1 |
| Chen, YH | 1 |
| Wang, JH | 1 |
| Ko, WC | 1 |
| Yu, KW | 1 |
| Liu, YC | 1 |
| Chen, YS | 1 |
| Tang, HJ | 1 |
| Hsueh, PR | 1 |
| Trinchieri, A | 1 |
| Marchetti, F | 1 |
| Gupta, R | 1 |
| Rauf, SJ | 1 |
| Singh, S | 1 |
| Smith, J | 1 |
| Agraharkar, ML | 1 |
| Liang, YJ | 1 |
| Zhai, XB | 1 |
| He, LX | 1 |
| Guo, ZL | 1 |
| Ren, T | 1 |
| He, ZG | 1 |
| Zhang, L | 1 |
| Zheng, YH | 1 |
| Fukuyama, M | 1 |
| Kawakami, K | 1 |
| Suda, O | 1 |
| Imagawa, Y | 1 |
| Gentry, LO | 1 |
| Rodriguez-Gomez, G | 1 |
| DeAbate, CA | 1 |
| Henry, D | 1 |
| Bensch, G | 1 |
| Jubran, A | 1 |
| Chodosh, S | 1 |
| Harper, L | 1 |
| Tipping, D | 1 |
| Talbot, GH | 1 |
| Dekitsch, C | 1 |
| Schein, R | 1 |
| Markopulos, E | 1 |
| Kuen, B | 1 |
| Graninger, W | 1 |
| Georgopoulos, A | 1 |
| Steward, CD | 1 |
| Stocker, SA | 1 |
| Swenson, JM | 1 |
| O'Hara, CM | 1 |
| Edwards, JR | 1 |
| Gaynes, RP | 1 |
| McGowan, JE | 1 |
| Tenover, FC | 1 |
| Liassine, N | 1 |
| Chelfi, A | 1 |
| Rahal, K | 1 |
| Bertrand, A | 1 |
| Janbon, F | 1 |
| Despaux, E | 1 |
| Jonquet, O | 1 |
| Reynes, J | 1 |
| Bernard, E | 1 |
| Etesse, H | 1 |
| Garraffo, R | 1 |
| Giaume, F | 1 |
| Dellamonica, P | 1 |
3 trials available for ofloxacin and Cronobacter Infections
| Article | Year |
|---|---|
[Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
Topics: Anti-Infective Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Enterobacteriaceae | 2003 |
Ofloxacin treatment of difficult infections of the skin and skin structure.
Topics: Abscess; Administration, Oral; Adult; Aged; Aged, 80 and over; Cellulitis; Drug Administration Sched | 1993 |
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamy | 1998 |
17 other studies available for ofloxacin and Cronobacter Infections
| Article | Year |
|---|---|
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross I | 2007 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cla | 2022 |
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Heal | 2014 |
Canaliculitis caused by Citrobacter freundii.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Canaliculitis; Cefazolin; Citrobacter freundii; Combined M | 2016 |
Iatrogenic gastric wall abscess infected with Enterobacter cloacae after biopsy.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Comb | 2010 |
Osteomyelitis after bilateral sagittal split osteotomy: case report and a review of the management.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Bone Plates; Bone Screws; Clindamycin; Drainage; Enterob | 2011 |
Prevalence of plasmid-mediated quinolone resistance determinants in Citrobacter freundii isolates from Anhui province, PR China.
Topics: China; Ciprofloxacin; Citrobacter freundii; Conjugation, Genetic; Drug Resistance, Bacterial; Entero | 2011 |
[A case of ventilator-associated pneumonia due to Pantoea agglomerans].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae | 2012 |
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Ente | 2012 |
Sepsis in a renal transplant recipient due to Citrobacter braakii.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Bacteremia; Cellulitis; Citrobacter freundi | 2003 |
Research and clinical value of antibacterial-application software.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Enterobacter cloaca | 2008 |
[In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Enteritis; Enterobacteriaceae Infections; Escheri | 1995 |
Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae.
Topics: Amino Acid Substitution; Anti-Infective Agents; Ciprofloxacin; Codon; Deoxyribonucleases, Type II Si | 1999 |
Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; | 1999 |
[Resistance to new quinolones among the enterobacteria].
Topics: Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Nalidixic Aci | 1992 |
[Ofloxacin (RU 43280). Clinical study].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Drug Therapy, Combination; Enterobacteriaceae Infect | 1987 |
[Bone infections: treatment by ofloxacin. Apropos of 10 cases].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Enterobacteriaceae Infections; | 1987 |